Suppr超能文献

神经节苷脂化学的新趋势。

New trends in ganglioside chemistry.

作者信息

Sonnino S, Ghidoni R, Gazzotti G, Acquotti D, Tettamanti G

机构信息

Department of Biological Chemistry, The Medical School, University of Milan, Italy.

出版信息

Adv Exp Med Biol. 1988;228:437-64. doi: 10.1007/978-1-4613-1663-3_16.

Abstract

New methods have been developed for the preparation of highly purified gangliosides, homogeneous in the saccharide, long chain base, and fatty acid moieties and gangliosides carrying different kinds of labelled probes. Gangliosides, homogeneous in the oligosaccharide portion, were prepared by preparative normal phase HPLC on a Lichrosorb-NH-2 column, using a gradient of acetonitrile-phosphate buffer, pH 5.6, as solvent system. Each class of ganglioside (from monosialo- to tetrasialogangliosides) was then submitted to reversed phase HPLC on a preparative RP-8 column, using acetonitrile-5 mM phosphate buffer, pH 7, as solvent system, to obtain gangliosides homogeneous in the long chain base moiety. Gangliosides containing C18 and C20 sphinganine were prepared by catalytic hydrogenation of the corresponding unsaturated gangliosides. GM1 with homogeneous acyl chain was prepared by alkaline hydrolysis in the presence of tetramethylammonium hydroxide (which forms a GM1 deacetylated at the level of sialic acid, and a GM1 deacetylated at the level of sialic acid and deacylated at the level ceramide), followed by re-N-acylation, carried out in the presence of dimethylaminopropyl, ethylcarbodiimide and natural fatty acids, or of mixed anhydride of ethylchloroformate and 14C-stearic acid, and re-N-acetylation performed with acetic anhydride or labelled acetic anhydride. The GM1 derivative, de-acetylated at the level of sialic acid, also produced by alkaline treatment of GM1, was submitted to re-N-acetylation with 14C-acetic anhydride to produce specifically 14C-labelled GM1. Re-N-acylation was carried out a) in the presence of dimethylaminopropyl, ethylcarbodiimide and natural fatty acids, b) with mixed anhydride of ethylchloroformate and 14C-stearic acid. After re-N-acylations, re-N-acetylation was performed with acetic anhydride or labelled acetic anhydride. Gangliosides tritium labelled in the oligosaccharide moiety were prepared by the galactose oxidase/3H NaBH4 method, and gangliosides tritium labelled at carbon-3 of unsaturated long chain bases by the dicyano-dichlorobenzoquinone (DDQ)/3H NaBH4 method.

摘要

已开发出制备高纯度神经节苷脂的新方法,这些神经节苷脂在糖、长链碱和脂肪酸部分是均一的,并且带有不同种类的标记探针。通过在Lichrosorb-NH-2柱上进行制备型正相高效液相色谱法,使用乙腈 - 磷酸盐缓冲液(pH 5.6)的梯度作为溶剂系统,制备了在寡糖部分均一的神经节苷脂。然后,将每一类神经节苷脂(从单唾液酸神经节苷脂到四唾液酸神经节苷脂)在制备型RP-8柱上进行反相高效液相色谱法,使用乙腈 - 5 mM磷酸盐缓冲液(pH 7)作为溶剂系统,以获得在长链碱部分均一的神经节苷脂。含有C18和C20鞘氨醇的神经节苷脂通过相应不饱和神经节苷脂的催化氢化制备。具有均一酰基链的GM1通过在氢氧化四甲铵存在下进行碱性水解制备(这会形成在唾液酸水平脱乙酰化的GM1,以及在唾液酸水平脱乙酰化且在神经酰胺水平脱酰化的GM1),随后在二甲基氨基丙基、乙基碳二亚胺和天然脂肪酸存在下进行再N-酰化,或者使用氯甲酸乙酯和14C-硬脂酸的混合酸酐进行再N-酰化,并使用乙酸酐或标记的乙酸酐进行再N-乙酰化。同样通过GM1的碱性处理产生的在唾液酸水平脱乙酰化的GM1衍生物,用14C-乙酸酐进行再N-乙酰化以产生特异性14C标记的GM1。再N-酰化在以下条件下进行:a)在二甲基氨基丙基、乙基碳二亚胺和天然脂肪酸存在下;b)使用氯甲酸乙酯和长链碱部分均一的神经节苷脂通过相应不饱和神经节苷脂的催化氢化制备。具有均一酰基链的GM1通过在氢氧化四甲铵存在下进行碱性水解制备(这会形成在唾液酸水平脱乙酰化的GM1,以及在唾液酸水平脱乙酰化且在神经酰胺水平脱酰化的GM1),随后在二甲基氨基丙基、乙基碳二亚胺和天然脂肪酸存在下进行再N-酰化,或者使用氯甲酸乙酯和14C-硬脂酸的混合酸酐进行再N-酰化,并使用乙酸酐或标记的乙酸酐进行再N-乙酰化。同样通过GMs的碱性处理产生的在唾液酸水平脱乙酰化的GM1衍生物,用14C-乙酸酐进行再N-乙酰化以产生特异性14C标记的GM1。再N-酰化在以下条件下进行:a)在二甲基氨基丙基、乙基碳二亚胺和天然脂肪酸存在下;b)使用氯甲酸乙酯和14C-硬脂酸的混合酸酐。再N-酰化后,用乙酸酐或标记的乙酸酐进行再N-乙酰化。在寡糖部分用氚标记的神经节苷脂通过半乳糖氧化酶/3H NaBH4法制备,在不饱和长链碱的碳-3处用氚标记的神经节苷脂通过二氰基二氯苯醌(DDQ)/3H NaBH4法制备。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验